EUVIMEDEUVIMED entdecken
Crossref

Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis

Keigo Nakaachi, Shoji Matsune, Norihiro Usukura, Kei Hosoya, Taro Komachi, Kimihiro Okubo, Minoru Gotoh

Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · 2026 · 65 (1) · 10-18

DOI: 10.7248/jjrhi.65.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 2026. Verfasst von Keigo Nakaachi und 6 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nakaachi, K., Matsune, S., Usukura, N., Hosoya, K., Komachi, T., Okubo, K., & Gotoh, M. (2026). Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis. Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 65(1), 10-18. https://doi.org/10.7248/jjrhi.65.10

Vancouver

Nakaachi K, Matsune S, Usukura N, Hosoya K, Komachi T, Okubo K, et al. Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis. Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology). 2026;65(1):10-18. doi:10.7248/jjrhi.65.10

BibTeX
@article{Nakaachi2026,
  author = {Nakaachi, Keigo and Matsune, Shoji and Usukura, Norihiro and Hosoya, Kei and Komachi, Taro and Okubo, Kimihiro and Gotoh, Minoru},
  title = {Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis},
  journal = {Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)},
  year = {2026},
  volume = {65},
  number = {1},
  pages = {10--18},
  doi = {10.7248/jjrhi.65.10}
}
Kostenlos starten →